Illumina, Inc. vs VanEck Rare Earth/Strategic Metals — how do they compare? Illumina, Inc. trades at $192.7 (market cap $27.94B), while VanEck Rare Earth/Strategic Metals trades at $72.06. The key difference: Illumina, Inc. is trading nearer its 52-week high, VanEck Rare Earth/Strategic Metals nearer its low. Which is the better fit depends on your goals.
| ILMN | REMX | |
|---|---|---|
Market Cap | $27.94B | — |
Sector | Health | Sector/Thematic |
52-Week High | $194.33 | $109.53 |
52-Week Low | $91.00 | $49.22 |
Enterprise Value | $29.33B | — |
Trailing returns across standard periods
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →REMX invests in global companies involved in producing, refining, and recycling rare earth and strategic metals. It provides targeted exposure to critical minerals used in high-tech and green energy, with top holdings like Albemarle and Pilbara Minerals.
Read more on REMX →